Digitisation of drug R&D: Avoiding new for novelty’s sake
AI and wearable medical devices are already advancing patient care, and transformative use of data and digital innovation is set to enable a new generation of medicines, faster.
In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.
For life sciences, Wasan makes clear, the domain-specific needs of the industry – the customers and the products – need to be fully understood when it comes to optimisation of new technologies and software. It mustn’t be a case of implementing new for novelty’s sake.
You can listen to episode 112a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, acast, Stitcher, and Podbean.
